E1	Modifier:T1 Modifies:T53
E2	Condition:T2 Name:T53 Temporality:E53
E3	Condition:T3 Name:T54
E4	Negation:T4 Negates:E6
E5	Modifier:T5 Modifies:T55
E6	Condition:T6 Name:T55
E7	Condition:T7 Name:T79
E8	Modifier:T8 Modifies:T79
E9	Modifier:T9 Modifies:T79
E10	Modifier:T10 Modifies:T79
E11	Modifier:T11 Modifies:T79
E12	Or:T12 Arg:E11 Arg2:E13
E13	Modifier:T13 Modifies:T79
E14	Or:T14 Arg:E7 Arg2:E15
E15	Modifier:T15 Modifies:T58
E16	Or:T16 Arg:E15 Arg2:E17
E17	Modifier:T17 Modifies:T58
E18	Modifier:T18 Modifies:T58
E19	Condition:T19 Name:T58
E20	Eq-Comparison:T20 Temporal-Recency:T56
E21	Procedure:T21 Temporality:E20
E22	Procedure:T22 Name:T59
E23	Assertion:T23 Asserted:E24
E24	Procedure:T24 Name:T60
E25	Eq-Comparison:T25 Operator:T61 Value:T62 Temporal-Unit:T63
E26	Age:T26 Eq-Comparison:E25
E27	Eq-Comparison:T27 Temporal-Period:T64
E28	Procedure:T28 Name:T65
E29	Or:T29 Arg:E28 Arg2:E30
E30	Procedure:T30
E31	Other:T31 Is-Other:E32
E32	Drug:T32 Name:T66
E33	Drug:T33 Name:T67
E34	Eq-Comparison:T34 Temporal-Period:T68
E35	Procedure:T35 Name:T69 Temporality:E34
E36	Drug:T36 Name:T70
E37	Or:T37 Arg:E36 Arg2:E38
E38	Procedure:T38 Name:T71
E39	Condition:T39 Name:T81
E40	Exception:T40 From:E39 Except:E42 Except2:E45
E41	Modifier:T41 Modifies:T72
E42	Condition:T42 Name:T72
E43	Or:T43 Arg:E42 Arg2:E45
E44	Modifier:T44 Modifies:T73
E45	Condition:T45 Name:T73
E46	Modifier:T46 Modifies:T74
E47	Condition:T47 Name:T74
E48	Or:T48 Arg:E47 Arg2:E49
E49	Condition:T49 Name:T75
E50	Or:T50 Arg:E49 Arg2:E52
E51	Modifier:T51 Modifies:T76
E52	Condition:T52 Name:T76
E53	Eq-Comparison:T77 Temporal-Recency:T78
E54	Exception:T57 From:E32 Except:E33
E55	Modifier:T80 Modifies:T81
T1	Modifier 63 94	locoregional oral squamous cell
T2	Condition 95 104	carcinoma
T3	Condition 106 110	OSCC
T4	Negation 112 119	without
T5	Modifier 132 139	distant
T6	Condition 140 150	metastases
T7	Condition 152 156	OSCC
T8	Modifier 170 193	subsites of oral tongue
T9	Modifier 195 209	floor of mouth
T10	Modifier 211 218	gingiva
T11	Modifier 220 238	retromolar trigone
T12	Or 239 242	and
T13	Modifier 243 256	buccal mucosa
T14	Or 257 259	OR
T15	Modifier 260 269	Recurrent
T16	Or 270 272	or
T17	Modifier 273 283	persistent
T18	Modifier 306 318	locoregional
T19	Condition 319 323	OSCC
T20	Eq-Comparison 333 342	initially
T21	Procedure 343 350	treated
T22	Procedure 356 363	surgery
T23	Assertion 384 396	eligible for
T24	Procedure 397 415	surgical resection
T25	Eq-Comparison 421 442	greater than 18 years
T26	Age 446 449	age
T27	Eq-Comparison 475 480	prior
T28	Procedure 481 494	immunotherapy
T29	Or 495 497	or
T30	Procedure 498 507	treatment
T31	Other 513 520	another
T32	Drug 521 536	anti PD-1 agent
T33	Drug 545 554	nivolumab
T34	Eq-Comparison 560 565	prior
T35	Procedure 566 578	chemotherapy
T36	Drug 589 598	cetuximab
T37	Or 599 601	or
T38	Procedure 602 619	radiation therapy
T39	Condition 637 649	malignancies
T40	Exception 650 656	except
T41	Modifier 657 680	cutaneous squamous cell
T42	Condition 681 690	carcinoma
T43	Or 691 693	or
T44	Modifier 694 704	basal cell
T45	Condition 705 714	carcinoma
T46	Modifier 720 740	unresectable primary
T47	Condition 741 746	tumor
T48	Or 747 749	or
T49	Condition 750 766	regional disease
T50	Or 767 769	or
T51	Modifier 770 777	distant
T52	Condition 778 788	metastases
T53	Condition-Name 95 104	carcinoma
T54	Condition-Name 106 110	OSCC
T55	Condition-Name 140 150	metastases
T58	Condition-Name 319 323	OSCC
T59	Procedure-Name 356 363	surgery
T60	Procedure-Name 397 415	surgical resection
T61	Eq-Operator 421 433	greater than
T62	Eq-Value 434 436	18
T63	Eq-Temporal-Unit 437 442	years
T64	Eq-Temporal-Period 475 480	prior
T65	Procedure-Name 481 494	immunotherapy
T66	Drug-Name 521 536	anti PD-1 agent
T67	Drug-Name 545 554	nivolumab
T68	Eq-Temporal-Period 560 565	prior
T69	Procedure-Name 566 578	chemotherapy
T70	Drug-Name 589 598	cetuximab
T71	Procedure-Name 602 619	radiation therapy
T72	Condition-Name 681 690	carcinoma
T73	Condition-Name 705 714	carcinoma
T74	Condition-Name 741 746	tumor
T75	Condition-Name 750 766	regional disease
T76	Condition-Name 778 788	metastases
T77	Eq-Comparison 25 30	Newly
T78	Eq-Temporal-Recency 25 30	Newly
T79	Condition-Name 152 156	OSCC
T56	Eq-Temporal-Recency 333 342	initially
T57	Exception 537 544	besides
T80	Modifier 625 636	concomitant
T81	Condition-Name 637 649	malignancies
A1	Assertion-Type-Value E23 hypothetical
A2	Eq-Operator-Value T61 GT
A3	Eq-Temporal-Unit-Value T63 year
A4	Eq-Temporal-Period-Value T64 past
A5	Eq-Temporal-Period-Value T68 past
A6	Eq-Temporal-Recency-Value T78 first-time
A7	Eq-Temporal-Recency-Value T56 first-time
R1	Example-Of Arg1:E3 Arg2:E2
R2	Treatment-For Arg1:E21 Arg2:E19
R3	Using Arg1:E21 Arg2:E22
R4	Equivalent-To Arg1:E28 Arg2:E27
R5	Using Arg1:E30 Arg2:E32
R6	Example-Of Arg1:E36 Arg2:E35
R7	Example-Of Arg1:E38 Arg2:E35